ERBB2 and breast cancer: According to the reports by Denkert et al. increased levels of TILs in woman receiving neoadjuvant chemotherapy were associated with improved prognosis in HER2+ or TNBC, but a poorer outcome in ER+/HER2− breast cancer [7].